LivaNova (LIVN) Gains from Investment Securities (2019 - 2026)
LivaNova (LIVN) posted Gains from Investment Securities of $10.7 million for Q1 2026, up 345.26% sequentially from $2.4 million in Q4 2025, and up 1055.64% YoY from $922000.0 in Q1 2025.
LivaNova (LIVN) Gains from Investment Securities (2019 - 2026) Analysis & Trends
LivaNova has reported Gains from Investment Securities for 8 years, with the latest figure at $10.7 million in Q1 2026.
- Quarterly Gains from Investment Securities rose 1055.64% year-over-year to $10.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.6 million (up 302.43% YoY) and the FY2025 annual result came in at $7.9 million, up 136.94% from the prior year.
- Gains from Investment Securities improved to $10.7 million in Q1 2026 per LIVN's latest filing, from $2.4 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $10.7 million in Q1 2026 and troughed at -$23.6 million in Q2 2022.
- A 5-year average of $76882.4 and a median of $1.8 million in 2025 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2025: Gains from Investment Securities slumped 932.89% in 2022, then jumped 2559.09% in 2025.
- Over 5 years, Gains from Investment Securities stood at $3.4 million in 2022, then surged by 40.73% to $4.8 million in 2023, then plunged by 38.52% to $3.0 million in 2024, then dropped by 19.64% to $2.4 million in 2025, then surged by 345.26% to $10.7 million in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $10.7 million, $2.4 million, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -151,000.00 |
| Jun 30, 2026 | -151,000.00 |
| Mar 31, 2026 | 10.66 Mn |
| Mar 31, 2026 | 10.66 Mn |
| Dec 31, 2025 | 2.39 Mn |
| Dec 31, 2025 | 2.39 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Jun 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 2.79 Mn |
| Mar 31, 2025 | 922,000.00 |
| Mar 31, 2025 | 922,000.00 |
| Dec 31, 2024 | 2.98 Mn |
| Dec 31, 2024 | 2.98 Mn |
| Sep 30, 2024 | 66,000.00 |
| Sep 30, 2024 | 66,000.00 |
| Jun 30, 2024 | 405,000.00 |
| Jun 30, 2024 | 405,000.00 |
| Mar 31, 2024 | -133,000.00 |
| Mar 31, 2024 | -133,000.00 |